Bioacoustic Therapy (Sound Frequency Therapy)

This page as PDF · Summary

1. What Bioacoustic Therapy Is

Bioacoustic therapy (also known as sound frequency therapy) is a physical modality that transmits targeted mechanical vibrations in the audible or low-frequency range to the body. Sound waves are applied via specialised devices, such as vibration plates, headphones, or local applicators. The method originates from early experimental work on vibroacoustics and pulsed radiofrequency in the 1980s. Today, it is used in various forms, including Vibroacoustic Therapy (VAT), Pulsed Radiofrequency (PRF), or Low-Frequency Stimulation. Treatment typically consists of a series of applications, with duration, frequency, and intensity adjusted according to the indication.

Critical to understanding the evidence base is the diversity of technical parameters: sound frequencies may be applied continuously or in pulses, locally or systemically, with varying pressure amplitudes and exposure durations. Additionally, target tissues—such as muscle, nerves, or internal organs—differ in their sensitivity to mechanical vibrations. Most studies measure subjective symptom changes (e.g., pain, fatigue) or functional markers (e.g., mobility, respiratory function), while biochemical or immunological effects are less frequently investigated. The lack of standardised application protocols complicates the comparability of results.

2. What the Studies Show in Detail

Key human studies—organised by application, including population, duration, preparation, outcome measures, and results as reported in the original publications. Numbers are included only where explicitly stated in the studies.

Distribution of controlled human studies by area of application — the figures are not additive, as a single study may be assigned to multiple areas:

Musculoskeletal System

The studies included patients with ACL injuries or reconstructions, although the number of participants per study was not explicitly stated in the abstract. The duration of the interventions varied but typically ranged from weeks to months. While the majority of the included studies focused on adjunctive therapies—mostly in combination with exercise therapy—these results are not specific to bioacoustic therapy. The methodological quality of the studies scored between 5 and 8 on the PEDro scale, indicating moderate to good quality. A limitation is that the heterogeneity of the study protocols complicates direct comparability, and the findings cannot be attributed to bioacoustic therapy alone.

An observational study from 2021 2 examined the effect of vibroacoustic therapy (VAT), a form of sound frequency therapy, in 60 patients following total knee replacement (TKR) or total hip replacement (THR). Participants were divided into two groups (based on type of surgery) and further allocated to either an experimental group (VAT using the VITAFON-2 device) or a placebo control group. Both groups additionally received standard hospital-based kinesiotherapy. VAT was applied during the first four postoperative days. Outcomes measured included the intensity of postoperative symptoms, range of motion of the operated joint, oedema in the operated limb, and resorption of haematomas. The results showed that VAT led to faster reduction of oedema and haematomas, as well as improved range of motion. However, the study has limitations: the short intervention period of only four days precludes conclusions about long-term effects, and the combination with kinesiotherapy makes it difficult to isolate the effect of VAT. Furthermore, the abstract lacks a detailed description of the exact sound frequencies or application protocols.

Hypothesis The available data suggest that sound frequency therapies such as VAT may be effective as adjuvant measures in the early postoperative phase or in acute muscle injury (AMI), particularly for reducing oedema and improving joint function. However, it remains unclear whether these effects are attributable to mechanical stimulation, neuronal modulation, or non-specific placebo effects. The combination with active exercise therapy appears to have a synergistic effect, underscoring the need for multimodal rehabilitation.

Viral Infections

A randomised controlled pilot study from 2023 1 investigated the effect of vibroacoustic therapy (VAT) in 60 hospitalised COVID-19 patients with respiratory insufficiency (grades 2 and 3 based on CT findings). Participants were divided into two groups, each treated with the VibroLung device in either 'ARDS' or 'pneumonia' mode. Both groups received identical standard therapies. VAT was administered as hardware-based massage, although the exact frequencies or duration of sessions were not specified in the abstract. Arterial blood gas values (PaO₂, PaCO₂) and the oxygenation index (P/F ratio) were measured before and after therapy. In the 'pneumonia' mode, the improvements in these surrogate parameters were less pronounced but still significant. The absence of a control group without VAT limits conclusions about the causal effects of VAT on clinical outcomes or respiratory function.

This study does not concern sound frequency therapy: it investigated the effect of pulsed radiofrequency waves (PRF) versus continuous epidural blockade (CEB) in patients with herpes zoster. Participants were randomised into one of two groups. The PRF group received a single treatment with pulsed radiofrequency waves, while the CEB group underwent continuous epidural blockade over several days. The primary endpoint was the incidence of postherpetic neuralgia (PHN) at 1, 3, and 6 months. Secondary endpoints included pain intensity (VAS), sleep quality (PSQI), and analgesic requirements (gabapentin, tramadol). The results showed that the CEB group had a significantly lower incidence of PHN at 1, 3, and 6 months compared to the PRF group (p < 0.05). Both groups demonstrated reductions in pain intensity and improvements in sleep quality, with the CEB group consistently achieving better outcomes. Limitations include the lack of a placebo control group and the absence of detailed descriptions of the intervention parameters.

Inflammatory Processes

This 2009 observational study examined dynamic magnetic field therapy (DMT) and transdermal electroneurostimulation (TDENS) in 473 patients with mandibular fractures and inflammatory periodontal diseases, comparing them to ultra-high-frequency therapy (UHF). While the combination of DMT and TDENS (using the AMO-ATOS-E device) reduced clinical symptoms of periodontitis twice as quickly as UHF and halved complication rates (e.g., delayed bone healing), the study does not investigate sound frequency therapies like bioacoustic therapy. Limitations include the lack of randomisation, blinding, and a control group without physical therapy, as well as unspecified parameters for DMT/TDENS.

Hypothesis The study suggests that electromagnetic therapies such as DMT and TDENS may possess anti-inflammatory and tissue-regenerative effects, particularly when combined with other therapies. However, it remains unclear whether these findings can be extrapolated to sound frequency therapies like bioacoustic therapy, as the mechanisms and modalities differ.

Overall Picture

The available studies demonstrate that sound frequency therapies—particularly vibroacoustic therapy (VAT)—exhibit potential adjuvant effects in various clinical contexts. In the musculoskeletal system, pilot data indicate accelerated postoperative rehabilitation (e.g., reduction of oedema, improvement of joint function) 2; in viral infections such as COVID-19, they briefly enhance oxygenation parameters in pilot settings 1; and in inflammatory processes, preclinical findings suggest effects on tissue regeneration, though these have not been confirmed in humans.

Across all fields, long-term data are lacking, as are studies systematically investigating the specific mechanisms of action of sound frequency therapies. In particular, it remains unclear whether the observed effects are attributable to mechanical stimulation, neuronal modulation, or non-specific placebo effects. Furthermore, there are no direct comparisons between different sound frequency therapies (e.g., VAT vs. pulsed radiofrequency) or standardised protocols. The evidence is thus in its early stages and requires larger, methodologically robust studies with clearly defined endpoints.

3. How Robust Is the Research?

The seven evaluated studies on bioacoustic therapy are divided into five human studies (three of which are controlled) and two foundational research papers. The controlled studies focus on antiviral effects (e.g., in COVID-19), immune modulation, fatigue, and the musculoskeletal system (e.g., following ACL injuries or joint replacement). The oldest study dates back to 1989, while the most recent is a 2026 publication on the prevention of postherpetic neuralgia. A notable trend is the recent increase in publications: three of the five human studies were published from 2023 onwards, indicating a growing but still small field of research.

The methodological robustness of the studies varies. The controlled studies demonstrate differing levels of quality: while the controlled study on arthrogenic muscle inhibition following ACL injuries (2024) includes bioacoustic therapy among multiple interventions, the other two controlled studies are pilot studies with small sample sizes. The observational studies provide indications of potential effects, such as in rehabilitation after joint replacement, but cannot establish causality. The foundational research papers (e.g., in ponies with experimental arthritis) suggest mechanistic approaches, such as the modulation of inflammatory processes, but remain preclinical and are not specific to bioacoustic therapy. A key weakness in the field is the lack of replication of results—many studies are isolated findings without independent confirmation.

4. What Is Frequently Claimed—and What the Data Support

5. The Most Robust Studies

Ranked by evidential strength, not by prominence. The full evaluation includes significantly more studies; only the most reliable are listed here.

Controlled Human Studies

• The Effect of Physiotherapy on Arthrogenic Muscle Inhibition After ACL Injury or Reconstruction: A Systematic Review (2024)
• 1 Vibroacoustic therapy in the treatment of patients with COVID-19 complicated by respiratory failure: a pilot randomised controlled trial (2023)
• Clinical study of the preventive effect of pulsed radiofrequency and continuous epidural block on postherpetic neuralgia: a randomised controlled trial (2026)

Observational Studies in Humans

• 2 Influence of vibroacoustic therapy on local status and rehabilitation of post-total knee replacement (TKR) and post-total hip replacement (THR) patients (2021)
• [Use of dynamic magnetotherapy and transdermal electroneurostimulation in the combined treatment of patients with mandibular fractures and concomitant conditions (2009)]

6. Summary

The available studies suggest that bioacoustic therapies, such as vibroacoustic therapy (VAT), show potential adjuvant effects in specific clinical contexts. In the musculoskeletal system, they may accelerate postoperative rehabilitation, for instance by reducing oedema and improving joint function, while in viral infections such as COVID-19, short-term improvements in respiratory function and fatigue scores have been observed. Preclinical findings in ponies with experimental arthritis suggest mechanistic approaches like modulation of inflammatory processes, though these effects have not yet been investigated in humans. However, these findings are largely based on small, heterogeneous studies with methodological limitations, such as the absence of placebo controls or insufficient blinding. Furthermore, systematic investigations into the underlying mechanisms of action are lacking, leaving it unclear whether the effects are attributable to mechanical stimulation, neuronal modulation, or non-specific factors such as relaxation or placebo.

Hypothesis The data suggest that sound frequency therapies could be effective as supportive measures in multimodal therapy, particularly in the early postoperative phase or during acute inflammatory processes. Combination with active movement therapy appears to have synergistic effects, underscoring the importance of integrative rehabilitation. However, the evidence is not yet sufficient to clearly define specific application protocols or target populations. Should indications of immunomodulatory or antiviral effects be confirmed in larger studies, this could open new avenues for supportive therapy in infectious diseases or chronic pain syndromes. Additionally, the targeted modulation of inflammatory processes through mechanical vibrations could represent a promising field of research for regenerative medicine.

To strengthen the evidence base, larger, methodologically robust studies with clearly defined endpoints and standardised therapy protocols would be required. In particular, the following questions would need to be systematically investigated: 1) Which frequencies, intensities, and modes of application are optimal for which indications? 2) Can the observed effects be confirmed in placebo-controlled studies, and how significant is the contribution of non-specific factors? 3) What biological mechanisms underlie the clinical effects—such as modulation of microcirculation, neuronal adaptation, or direct cellular responses to mechanical stimuli? 4) How sustainable are the effects, and what long-term outcomes are observed in chronic conditions? Only through such studies could bioacoustic therapy evolve from an empirical approach to an evidence-based treatment option.

7. Unresolved Questions

• Mechanism: Which physiological processes are actually influenced by sound frequencies—and how specific is this effect?
• Standardisation: Which frequencies, modes of application, and exposure durations are optimal for which indications?
• Placebo control: How significant is the contribution of non-specific effects to the observed clinical improvements?